$17.03
In chiusura: Sep 25, 5:00 PM EST
$17.04
0.0140.08%
Post-mercato: Sep 23, 5:58 PM EST
Theravance Biopharma Inc
TBPHNASDAQ
Fusioni e acquisizioni: Theravance Biopharma (TBPH) was acquired by Zymeworks (ZYME) on Wednesday, September 23, 2026 for $929M paid in cash
Theravance Biopharma Ownership & Insider Activity
Theravance Biopharma (TBPH) institutional and insider ownership, recent insider transactions and ownership breakdown.
Insiders own 14.3% of shares outstanding. Institutional investors hold 28.1%. Over the past 90 days, insiders made 3 sales worth $6.1M.
Shares Outstanding
51.919M
Shares Float
32.531M
Insider Shares Owned
7.413M
Insider % Owned
14.3%
Institutional Shares Held
14.596M
Institutional % Held
28.1%
Ownership Breakdown
Net Insider Activity by Month
Purchases (90d)
0
Sales (90d)
3
$6.1M total
Net Activity
Net Selling
Net Value (90d)
-$6.1M